Welcome to the Venture Café Calendar!
Life Sciences Pitch Event Featuring Korean Startups, Presented by KOTRA
November 14 @ 5:00 pm - 8:00 pm EST
Join us on November 14, 2019, for a special pitch featuring Korean startups and a bit of Korean culture.
Ten venture-backed startups will travel from South Korea to Cambridge to share the latest advances and disruptive applications in the life sciences sector. During the event, each startup will have an opportunity to pitch local Boston area experts and the Venture Cafe community for feedback. Come to learn, share your feedback, and make valuable connections with fellow entrepreneurs from Asia. Each startup will host a demo during the Café for expanded connection time. And if you are not familiar with our community, we will also have Korean culture for you to experience.
DEMOS – 5:00 PM – 5:45 PM (5th Floor – Venture Café)
PITCH EVENT – 5:45 PM – 7:00 PM (4th Floor)
DEMOS – 7:00 PM – 8:45 PM (5th Floor – Venture Café)
As a series B funded startup, we are developing optimized RNA sequences and RNA delivery technology that deliver mRNA or microRNA regulators effectively and safely. Delivering multiple mRNAs at once into the cytoplasm can mimic multi-protein complexes that function as epigenetic enzymes. Delivered microRNA regulators can control multiple protein function impaired diseases like neurodegenerative disease. Moreover, unlike DNA-targeting therapeutics like gene therapy, which may insert into chromosome permanently, RNA-based therapeutics can be temporary and this leads to reducing the risk of irreversible cellular DNA changes which may induce tumorigenesis.
We provide personalized health service with genetic risk prediction and early diagnosis of ALZHEIMER’S DISEASE via genomics, neuroimaging, and deep learning technology. Diagnosis of Dementia based on imaging genetics and personalized medical diagnosis system.
OTOPLANE is an innovator in the healthcare and diagnosis industry, developing a PCT molecular and immunoassay diagnostic platform embedded in a bio application-specific CMOS sensor device. Optane’s core technologies are the integration of CMOS sensors with the fluorescent optical and thermal control systems in order to detect target genes or antigen-antibody reaction.
Plasmapp Co., Ltd. is an innovative manufacturing company specializing in plasma technologies that originated at the Korea Advanced Institute of Science and Technology (KAIST). Based on this technology, Plasmapp has devised a novel plasma sterilizer for medical tools. This technology is made possible by our STERPACK® packaging pouches, which feature a fast sterilization cycle time and allow sterilization to below temperature.
Red Submarine has supported the development and commercialization of various types of modules required for function implementation in the IoT market as a manufacturer of sensor-based modules. Dr.Fish is a multi-functions health care assistant device. The functions of each device (especially for healthcare) were designed to be utilized as needed based on optimized module technology. It is possible to make up for the shortcomings of wearable devices and to envision business models linked to home care, nursing and insurance products.
500,000 new cases of spinal cord injury occur globally every year, however, there is still no cure. SuPine gel from SuPine Therapeutics is a hydrogel-based therapeutic under development which is intended to cure spinal cord injury. Preclinical trials conducted on the spinal cord injury animal model displayed the high efficacy and no toxicity of SuPine gel. As Spinal cord injury can be classified as an orphan disease, SuPine gel would be benefited with Fast-Track and Orphan drug policies from FDA, EMA, and Swissmedic. SuPine gel is applied to extend the treatment of nerve damage and scars in the human body.
THE.WAVE.TALK is a startup established in 2016 based on an original technology transferred from Korea Advanced Institute of Science and Technology (KAIST). Our new Laser technology can detect micro-substances such as microplastics and invisible bacteria inside liquids quickly and easily. Combined with deep learning, our technology aims to classify and identify certain types of bacteria in hospitals and/or factory settings. Regarding AST (Antibiotic Susceptibility Test), we can get results quickly, thus we can give an infected patient a quick and accurate prescription of antibiotics.
Xcell Therapeutics is a venture company developing a next-generation cell therapy product ‘CellCor’, a Serum-free Chemically defined Media. As our slogan “Better solution provider for Better Cell therapy”, our innovative technology is the most important key component in Cell&Gene therapy, Exosomes, Bio 3D printing, Meat culturing, Engineered tissues markets embracing all regenerative medicine. We are planning to develop different media for other cell lines and further develop into CMO/CDMO business based on the technology.
About our Sponsor